University of Alabama at Birmingham at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
University of Alabama at Birmingham brings 3 presentations to AMP 2026 in Seattle. Its programme covers gene fusion detection, image-based classification of lung cancer, and infectious-disease testing. Topics include comparing bone marrow with peripheral blood for RNA-based fusion gene detection and classifying lung cancers with FGFR3-TACC3 fusions from whole slide images.
| Organization | AMP 2026 Attendance |
|---|---|
University of Alabama at Birmingham Birmingham, AL | |
Public research university and academic medical centre in Birmingham with clinical molecular pathology and next-generation sequencing laboratories. | Poster Sat, Nov 14 1:15pm–1:30pm Poster Sat, Nov 14 1:30pm–1:45pm Talk Sat, Nov 14 3:15pm–4:00pm Beyond the Swab: The Evolution of STI Diagnostics Sexually transmitted infection testing: choosing between lab-based, point-of-care and over-the-counter options for a given population. |
Instantly find 20 buyers from University of Alabama at Birmingham
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction